Observational Study of miRNA in Pediatric Sepsis
This observational study is looking at how certain tiny molecules called micro RNA (miRNA) change in children with sepsis. Sepsis is a serious condition where the body's response to an infection damages its own tissues and organs. Researchers want to see if these miRNA levels can help identify sepsis early and how they change as children receive treatment. You might be able to join if you are between 1 and 18 years old and are admitted to the hospital with concerns for sepsis, or develop sepsis during your stay. The study aims to understand if miRNA can help predict the risk of death during a hospital stay, which is expected to be about three weeks. The current status of this study is unclear, and it plans to include 50 participants.
- Study design
- This is an observational study, meaning researchers will collect information without giving any new treatments. It plans to enroll 50 participants.
- What's involved
- You would provide blood samples, urine samples, and cheek swabs at five different times. Researchers will also collect information about your health during your hospital stay.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary endpoint, risk of mortality, is measured during the duration of your hospital stay, which is an expected average of 3 weeks.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Modulation of Molecular Fingerprinting in Pediatric Sepsis
At a glance
Conditions
Where it's being run
2 sites across 1 statesStudy leadership
- Frederick A Willyerd, MD · PRINCIPAL_INVESTIGATOR · Phoenix Children's Hospital
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Risk of MortalityDuration of hospital stay, an expected average of 3 weeks
Will compare PRISM 3 scores from baseline to hospital discharge.